SC 13G: Ventas, Inc.

Ticker: VTR · Form: SC 13G · Filed: 2024-11-14T00:00:00.000Z

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by Ventas, Inc..

Risk Assessment

Risk Level: low

From the Filing

0001104659-24-119076.txt : 20241114 0001104659-24-119076.hdr.sgml : 20241114 20241114164509 ACCESSION NUMBER: 0001104659-24-119076 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ardent Health Partners, Inc. CENTRAL INDEX KEY: 0001756655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 611764793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-94740 FILM NUMBER: 241463636 BUSINESS ADDRESS: STREET 1: 340 SEVEN SPRINGS WAY STREET 2: SUITE 100 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 6152963000 MAIL ADDRESS: STREET 1: 340 SEVEN SPRINGS WAY STREET 2: SUITE 100 CITY: BRENTWOOD STATE: TN ZIP: 37027 FORMER COMPANY: FORMER CONFORMED NAME: Ardent Health Partners, LLC DATE OF NAME CHANGE: 20181022 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Ventas, Inc. CENTRAL INDEX KEY: 0000740260 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 611055020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 353 N. CLARK STREET STREET 2: SUITE 3300 CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: 3126603800 MAIL ADDRESS: STREET 1: 353 N. CLARK STREET STREET 2: SUITE 3300 CITY: CHICAGO STATE: IL ZIP: 60654 FORMER COMPANY: FORMER CONFORMED NAME: VENTAS INC DATE OF NAME CHANGE: 19980507 SC 13G 1 tm2428527d1_sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Ardent Health Partners, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 03980N107 (CUSIP Number) July 17, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13d-1(b) ¨ Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ). SCHEDULE 13G CUSIP No. 03980N107 1 Names of Reporting Persons Ventas, Inc. 2 Check the appropriate box if a member of a Group (see instructions) (a) o (b) o 3 Sec Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 9,342,501 (1) 6 Shared Voting Power 0 7 Sole Dispositive Power 9,342,501 (1) 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 9,342,501 (1) 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) ¨ 11 Percent of class represented by amount in row (9) 6.55% (2) 12 Type of Reporting Person (See Instructions) CO (1) Ventas, Inc.’s beneficial ownership of the Issuer’s common stock consists of 9,342,501 shares of common stock held by ALH Holdings, LLC. Ventas, Inc., as the sole stockholder of VTR AMS, Inc., the sole and managing member of ALH Holdings, LLC, has voting and dispositive power of the shares held by ALH Holdings, LLC. (2) Calculation based on 142,732,815 shares of the Issuer’s common stock outstanding as of November 7, 2024, as reported in the Issuer&

View on Read The Filing